Predicting levodopa-induced dyskinesia

Predicting levodopa-induced dyskinesia

Saved in:

Bibliographic Details
Main Author:	Peter KEMPSTER
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações
Series:	Arquivos de Neuro-Psiquiatria
Online Access:	http://www.scielo.br/pdf/anp/v78n4/1678-4227-anp-0004-282x20200023.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
by: Bruno Lopes SANTOS-LOBATO, et al.
Published: (2020-04-01)

Low-frequency rTMS of pre-SMA as an intervention for levodopa-induced dyskinesia
by: Hartwig R. Siebner, et al.
Published: (2025-01-01)

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
by: Bruno Lopes Santos-Lobato, et al.
Published: (2023-05-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Baseline [18F]FP-CIT PET-based deep learning prediction of levodopa-induced dyskinesia in Parkinson’s disease
by: Grace Yoojin Lee, et al.
Published: (2025-05-01)

Evaluation of the potential therapeutic effect of africanized honeybee venom (Apis mellifera Linnaeus) on levodopa-induced dyskinesias in mice
by: CAMILA G. DANTAS, et al.
Published: (2025-06-01)

Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding
by: Svetlana A. Ivanova, et al.
Published: (2016-01-01)

Inefficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease Patients with Levodopa-Induced Dyskinesias: Results from a Pilot Study
by: Alma Medrano-Hernández, et al.
Published: (2025-07-01)

Translational profiling reveals novel gene expression changes in the direct and indirect pathways in a mouse model of levodopa induced dyskinesia
by: Sabika Jafri, et al.
Published: (2025-03-01)

Erratum to “Potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model” [Phytomedicine Plus Volume 2, Issue 4 (November 2022) 100334]
by: Pegah Ashrafi, et al.
Published: (2025-05-01)

Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia
by: E. E. Vayman, et al.
Published: (2020-01-01)

Dyskinesia induced by phenytoin Discinesia induzida por fenitoína
by: M. AUGUSTA MONTENEGRO, et al.
Published: (1999-06-01)

Primary ciliary dyskinesia
by: Plavec Goran, et al.
Published: (2004-01-01)

Primary ciliary dyskinesia
by: Sandra Rovira-Amigo, et al.
Published: (2025-01-01)

Post-stroke dyskinesias
by: Nakawah MO, et al.
Published: (2016-11-01)

A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
by: Edwige Heitzmann, et al.
Published: (2016-01-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

Levodopa and relief of parkinsonian symptons
by: P. Schmidt, et al.
Published: (1971-03-01)

Levodopa in hepatic coma in children
by: S Ozsoylu, et al.
Published: (1975-01-01)

Levodopa and relief of parkinsonian symptons
by: P. Schmidt, et al.
Published: (1971-03-01)

Experience in using levodopa-benserazide
by: Elena Anatolyevna Katunina, et al.
Published: (2015-10-01)

USE OF THREE-COMPONENT LEVODOPA (LEVODOPA/CARBIDOPA/ENTACAPONE) TO CORRECT NOCTURNAL SYMPTOMS OF PARKINSON,S DISEASE
by: T. K. Kulua, et al.
Published: (2015-08-01)

Primary Ciliary Dyskinesia Registry
by: Mohammadreza Modaresi, et al.
Published: (2024-01-01)

Improvement of Tardive Dyskinesias with Olanzapine
by: S. Echater, et al.
Published: (2023-01-01)

Paroxysmal Kinesigenic Dyskinesia and Epilepsy
by: J Gordon Millichap
Published: (2000-08-01)

Primary Ciliary Dyskinesia in Children
by: Alexander A. Baranov, et al.
Published: (2018-02-01)

Foetal Cell Transplantation for Parkinson’s Disease: Focus on Graft-Induced Dyskinesia
by: Elisabetta Tronci, et al.
Published: (2015-01-01)

Pharmaceutical-Induced Dyskinesia: A Case Study of Thoracotomy Treated with Amantadine
by: Mojtaba Mojtahedzadeh, et al.
Published: (2025-02-01)

Prosodic expression and levodopa in Parkinson's disease
by: Mara Behlau
Published: (2013-11-01)

Mortality in Levodopa-Treated Parkinson's Disease
by: John C. Morgan, et al.
Published: (2014-01-01)

On Levodopa Interactions with Brain Disease Amyloidogenic Proteins at the Nanoscale
by: Talia Bergaglio, et al.
Published: (2025-04-01)

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
by: Sylvia Navailles, et al.
Published: (2012-01-01)

Surgical mask-induced dyskinesia: a rare COVID-19 pandemics complication
by: Thiago Yoshinaga Tonholo Silva, et al.
Published: (2023-07-01)

Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia
by: E. E. Vaiman, et al.
Published: (2020-12-01)

Valbenazine for the Treatment of Adults with Tardive Dyskinesia
by: Harshit Gupta, et al.
Published: (2021-06-01)

Primary ciliary dyskinesia: A review
by: Shally Awasthi, et al.
Published: (2025-01-01)

Paroxysmal Kinesigenic Dyskinesia and Infantile Convulsions
by: J Gordon Millichap
Published: (2012-11-01)

RÜLFS CRAMP AND OTHER PAROXYSMAL DYSKINESIA
by: M. V. Selikhova, et al.
Published: (2016-05-01)

Method of Tremor Levodopa Responsiveness Assessment and Its Correlation With Clinical Factors in Parkinson’s Disease: Outcomes of the Acute Levodopa Challenge Test
by: Fangfei Li, et al.
Published: (2025-01-01)